Yuko Kusakabe Selected Research

Yuko Kusakabe Research Topics

Disease

11	Neoplasms (Cancer) 05/2023 - 03/2017
10	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 03/2017
3	Fibrosis (Cirrhosis) 01/2023 - 01/2020
2	Liver Neoplasms (Liver Cancer) 11/2021 - 04/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 10/2018
2	Body Weight (Weight, Body) 02/2004 - 08/2003
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2023
1	Multiple Organ Failure (MODS) 03/2023
1	Candidemia 03/2023
1	Jaundice (Icterus) 03/2023
1	Pathologic Constriction (Stenosis) 03/2023
1	Carcinogenesis 03/2023
1	Inflammation (Inflammations) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Liver Abscess 10/2022
1	Acute Cholecystitis 05/2022
1	Neoplasm Metastasis (Metastasis) 04/2021
1	Circulating Neoplastic Cells 04/2021
1	Adenocarcinoma 04/2021
1	Confusion (Bewilderment) 02/2021
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Stomach Neoplasms (Stomach Cancer) 09/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Edema (Dropsy) 01/2020
1	Ascites 01/2020
1	Gallbladder Neoplasms (Gallbladder Cancer) 10/2018
1	Carcinoma (Carcinomatosis) 07/2018
1	Fanconi Anemia (Fanconi's Anemia) 01/2017
1	Cholangitis 08/2015
1	Obstructive Jaundice (Cholestatic Jaundice) 08/2015

Drug/Important Bio-Agent (IBA)

3	Sorafenib (BAY 43-9006)FDA Link 11/2021 - 01/2020
2	UNC1999IBA 05/2023 - 11/2021
2	BilirubinIBA 05/2022 - 04/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2019
2	Hormones (Hormone)IBA 02/2004 - 08/2003
2	LeptinIBA 02/2004 - 08/2003
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2023
1	MHC class I-related chain AIBA 03/2023
1	micaIBA 03/2023
1	LigandsIBA 03/2023
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2023
1	ceramide glucosyltransferaseIBA 01/2023
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	CollagenIBA 01/2023
1	miglustat (Zavesca)FDA Link 01/2023
1	PlasticsIBA 10/2022
1	AlbuminsIBA 05/2022
1	C-Reactive ProteinIBA 05/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	atezolizumabIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 04/2021
1	Sweetening Agents (Sweeteners)IBA 02/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	lenvatinibIBA 01/2021
1	Angiopoietin-2IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	InterferonsIBA 09/2020
1	B7-H1 AntigenIBA 09/2020
1	regorafenibIBA 01/2020
1	Tolvaptan FDA Link 01/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2019
1	MetalsIBA 07/2018
1	Serum AlbuminIBA 04/2018
1	DNA (Deoxyribonucleic Acid)IBA 04/2018
1	BIX 01294IBA 03/2017
1	Histone-Lysine N-MethyltransferaseIBA 03/2017
1	Leptin ReceptorsIBA 02/2004

Therapy/Procedure

3	Stents 10/2022 - 08/2015
2	Pancreaticoduodenectomy 12/2020 - 08/2015
1	Cholecystectomy 03/2023
1	Immunotherapy 01/2022
1	Pancreatectomy 12/2020
1	Therapeutics 01/2020
1	Endoscopic Sphincterotomy 10/2018
1	Radiofrequency Ablation 04/2018
1	Laryngectomy 01/2017